Evidence map›Paper›PMID 35925980›Full record

ArticlePloS one2022

Disentangling personalized treatment effects from "time-of-the-day" confounding in mobile health studies.

Elias Chaibub Neto, Thanneer M Perumal, Abhishek Pratap, Aryton Tediarjo, Brian M Bot, Lara Mangravite, Larsson Omberg

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elias Chaibub NetoSage Bionetworks, Seattle, Washington, United States of America.ORCID 0000-0002-9575-861X
Thanneer M PerumalSage Bionetworks, Seattle, Washington, United States of America.
Abhishek PratapSage Bionetworks, Seattle, Washington, United States of America.ORCID 0000-0002-5289-6932
Aryton TediarjoSage Bionetworks, Seattle, Washington, United States of America.
Brian M BotSage Bionetworks, Seattle, Washington, United States of America.
Lara MangraviteSage Bionetworks, Seattle, Washington, United States of America.
Larsson OmbergSage Bionetworks, Seattle, Washington, United States of America.ORCID 0000-0002-4719-9120

Funding

The Clinical Core will support in-person and virtual research visits for three of the four Research Projects at the University of Rochester Udall CenterP50NS108676 · NINDS · UNIVERSITY OF ROCHESTER · PI DORSEY, EARL RAY · 2018 to 2022
$9.2M
Tele-Health Extension for Phase 3 Parkinson's Disease Trial CohortsU01NS107009 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI DORSEY, EARL RAY, SCHWARZSCHILD, MICHAEL A · 2018 to 2022
$4.1M
NINDS NIH HHS P50 NS108676NINDS NIH HHS U01 NS107009
6 · The paper itself

Abstract

Ideally, a patient's response to medication can be monitored by measuring changes in performance of some activity. In observational studies, however, any detected association between treatment ("on-medication" vs "off-medication") and the outcome (performance in the activity) might be due to confounders. In particular, causal inferences at the personalized level are especially vulnerable to confounding effects that arise in a cyclic fashion. For quick acting medications, effects can be confounded by circadian rhythms and daily routines. Using the time-of-the-day as a surrogate for these confounders and the performance measurements as captured on a smartphone, we propose a personalized statistical approach to disentangle putative treatment and "time-of-the-day" effects, that leverages conditional independence relations spanned by causal graphical models involving the treatment, time-of-the-day, and outcome variables. Our approach is based on conditional independence tests implemented via standard and temporal linear regression models. Using synthetic data, we investigate when and how residual autocorrelation can affect the standard tests, and how time series modeling (namely, ARIMA and robust regression via HAC covariance matrix estimators) can remedy these issues. In particular, our simulations illustrate that when patients perform their activities in a paired fashion, positive autocorrelation can lead to conservative results for the standard regression approach (i.e., lead to deflated true positive detection), whereas negative autocorrelation can lead to anticonservative behavior (i.e., lead to inflated false positive detection). The adoption of time series methods, on the other hand, leads to well controlled type I error rates. We illustrate the application of our methodology with data from a Parkinson's disease mobile health study.

Indexed as

Precision MedicineTelemedicineCausalityHumansLinear ModelsSmartphone

Identifiers

PMID35925980
PMCPMC9352058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.